adinazolam mesylate

The pharmacokinetics and pharmacodynamics of adinazolam mesylate (10 mg), N-desmethyl adinazolam mesylate (NDMAD, 10 mg), and… (More)

A novel optical image analysis method was developed to examine the dynamic swelling behavior of hydroxypropyl methylcellulose… (More)

The effect of adinazolam release rate on psychomotor performance and sedation was assessed by administering 40 mg adinazolam… (More)

Adinazolam, a triazolobenzodiazepine, has been studied in the treatment of depression, panic disorder and anxiety. N… (More)

The mechanism of release from sustained-release adinazolam mesylate tablets was assessed by the Higuchi equation and by analysis… (More)

The pharmacokinetics of adinazolam and N-desmethyladinazolam (NDMAD) were studied in 14 healthy male volunteers who received 15… (More)

In 72 outpatients with DSM-III major depressive episode, adinazolam was superior to placebo in all measurements. Significantly… (More)

Adinazolam mesylate, a new triazolobenzodiazepine with antidepressant properties, was significantly superior to placebo based on… (More)

In a 6-week, randomized, double-blind study, adinazolam mezylate (Deracyn Tablets, The Upjohn Company) was compared with placebo… (More)

A procedure for the quantitative determination of adinazolam in plasma was developed. The drug, an N-demethylated metabolite, and… (More)